SCHEMBL9997388

SCHEMBL9997388

CC(=O)OCC(=Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
PAM P19021 1/20 0.44
AKR1C3 P42330 1/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
RECQL P46063 1/20 0.41
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NR1H4 Q96RI1 1/20 0.41
CES2 O00748 1/20 0.40
CES1 P23141 1/20 0.40
AKR1B1 P15121 1/20 0.40
LMNA P02545 1/20 0.40
NR1I2 O75469 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9997387 1.00 ALDH1A1 (0.50) ALDH1A1CYP3A4CYP2C9KMT2AMEN1
SCHEMBL9997509 0.91 KMT2A (0.48) ALDH1A1CYP3A4CYP2C9KMT2AMEN1
SCHEMBL9997511 0.91 KMT2A (0.48) ALDH1A1CYP3A4CYP2C9KMT2AMEN1
SCHEMBL9997615 0.90 ALDH1A1 (0.44) ALDH1A1CYP3A4CYP2C9KMT2AMEN1
SCHEMBL9998644 0.90 ALDH1A1 (0.44) ALDH1A1CYP3A4CYP2C9KMT2AMEN1
SCHEMBL9997617 0.90 ALDH1A1 (0.44) ALDH1A1CYP3A4CYP2C9KMT2AMEN1
SCHEMBL9998195 0.90 L3MBTL1 (0.44) ALDH1A1CYP3A4CYP2C9KMT2AMEN1
SCHEMBL9998193 0.90 L3MBTL1 (0.44) ALDH1A1CYP3A4CYP2C9KMT2AMEN1
SCHEMBL9997518 0.90 ALDH1A1 (0.44) ALDH1A1CYP3A4CYP2C9KMT2AMEN1
SCHEMBL9997520 0.90 ALDH1A1 (0.44) ALDH1A1CYP3A4CYP2C9KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 ALDH1A1 160/4885CYP3A4 36/4885CYP2C9 28/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.